chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1633 got in my vehicle, my lips and tongue were swelling.  Arrived to ER @ 1650, quickly admitted for acute allergic reaction, anaphylactoid with wheezing and mild angioedema.  Received epinephrine, IV decadron, IV benadryl, IV pepcid, IVF, albuterol, and atrovent. Discharged from ER at approximately 2000
2 local satellite lesion. Systemic flu like Sx. Mild eruption consistent with foliculitis.
a skin rash appeared on all extremities and trunk of body as well as neck. Rash in the form of welts. Very itchy.; a skin rash appeared on all extremities and trunk of body as well as neck. Rash in the form of welts. Very itchy.; Rash in the form of welts. Very itchy.; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for himself that a 12-years-old male patient received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: Ew0181), via an unspecified route of administration in left arm on 06Jul2021 (at the age of 12-years-old) at 14:30 as dose 2, single for COVID-19 Immunization. Facility the most recent COVID-19 vaccine was administered was pharmacy or drug store. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: unspecified), via an unspecified route of administration on an unspecified date as historical vaccine as dose 1, single for COVID-19 Immunization. On 11Jul2021 at 21:30, the patient experienced 5 days after 2nd dose, a skin rash appeared on all extremities and trunk of body as well as neck. Rash in the form of welts. Very itchy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not received treatment for the adverse event. The outcome of the adverse event was recovering.
This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of arthropathy (knee problem) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19  vaccine) for COVID-19 immunization. No medical history reported. On Feb 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 31, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced arthropathy (knee problem). The patient treated with ibuprofen for unspecified disorder of knee joint, at a dose of 1 dosage form. At the time of the report, arthropathy (knee problem) outcome: unknown/not provided. For mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; dosing remained unchanged. No concomitant medication reported. Action taken with mRNA-1273 in response to the drug: N/A.
cardiac events/cardiac issues; This is a spontaneous report from a contactable Nurse.  A female patient of an unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 as a single dose for COVID-19 immunisation, lot number: unknown. Medical history and concomitant medications were not provided. It was reported that patient was hospitalized on unknown date due to cardiac events/ cardiac issues (onset date unknown). The nurse was caring for a patient who received the first (1 st) dose of the vaccine in the beginning of Jan2021, then wound up sick and in the hospital. The patient's second (2 nd) dose was due around the 20th or 21Jan2021, but the patient missed the dose due to being in the hospital. Nurse wanted to know if patient should she be getting the 2nd dose now or restarting the series. Nurse stated that the patient did not have an adverse event to the vaccine; she had unrelated cardiac issues. Outcome of the event was unknown.  information about Lot/ Batch number requested.; Sender's Comments: The reported cardiac disorder was most likely an intercurrent/concurrent disease, and unrelated to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE).
Seven days, post vax, my son developed a fever of 100.2F, diarrhea and vomiting that has lasted for seven days now.
Patient had been asymptomatic following the myopericarditis, which developed on 3/27/2003, ten days following his smallpox vaccine. On November 18, 2003 he received his influenza vaccine and reports that with in 3 days he began to feel a general "run-down" feeling. At that time he also began to experience a discomfort in the left side of his chest. He describes this as "pressure" and rates the intensity as a 3/10. He reports that it has not been continuous, coming and going.  He initially did not think that the discomfort was related to the influenza vaccine or a repeat of his myopericarditis, due in part to the fact that the discomfort was not as intense as what was experienced on prior occasions. Therefore, he did not seek medical attention for approximately one month after symptoms began. He was seen by a doctor on January 7, 2004 at which time his ECHO was within normal limits with an ejection fraction of 68%.
Information has been received on 15-FEB-2019 regarding a case in litigation from a lawyer concerning an 80 year old male patient. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 01-JAN-2007, the patient was administered the ZOSTAVAX (lot number, expiration, dose and route unknown) by a healthcare provider. On or about 01-MAR-2017, the patient was treated by a physician for the following injuries resulting from the patient's ZOSTAVAX use: shingles. The patient claims damages as a result of injury to self and economic losses. The outcome of the event is unknown. The causality of the event is related. Additional information has been requested.
Throwing up; This is a spontaneous report from a contactable consumer (patient's wife). A 91-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3247), via an unspecified route of administration in left arm, on 21Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the COVID-19 vaccine along with his wife this morning, at 10 AM. They were both monitored for 15 minutes post-vaccination (waited 15 minutes). Shortly after being home on 21Jan2021 (10 minutes after getting home), the patient started throwing up and seemed to be alright now. The patient's wife asked if she should be concerned and if this experience was reported as a side effect after vaccination; if the patient's vomiting is from the shot or not. The patient recovered from the event on 21Jan2021.
Patient called around 10:43 am, described waking up to an itchy red rash that broke out on her neck and hairline on the side that her vaccine was administered. According to description, reaction sounded allergic in nature, inquired if additional symptoms were present such as difficulty breathing, swelling, etc, but no other symptoms were present at that time. Recommended that I could evaluate in person if she came to the store, that she could take benadryl to aid in relieving allergic symptoms but cautioned drowsiness. Recommended seeking medical care if worsening of symptoms or new symptoms appeared such as swelling or difficulty breathing or no relief of symptoms within a reasonable amount of time.
Significant abdominal pain, irregular heart rate (120+ while sitting), nausea and fever (100+) for 1.5 days. Went away without treatment.
Treatment of COVID-19; Treatment of COVID-19; Pfizer / BioNTech - Dose Number: 3/Moderna - Dose Number: 4; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Mar2021 as dose 1, single (Lot number: EN6203), on 25Mar2021 as dose 2, single (Lot number: ER8734), in left arm and on 15Oct2021 as dose 3 (booster), single (Lot number: FF2590) at the age of 70 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 05Jul2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Ibuprofen, reaction(s): "Known allergies: Ibuprofen". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 05Jul2022, outcome "unknown", described as "Pfizer / BioNTech - Dose Number: 3/Moderna - Dose Number: 4"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient used Paxlovid as treatment of COVID 19 from 08Nov2022 to 12Nov2022.
At around 4PM PST, Monday, July 20th, I received my second vaccine dose of Shingrix 50MCG at a Pharmacy. I had received my first dose on 01/29/20. With my first dose I had no memorable reaction. With this second dose I had a significant reaction, though not life-threatening. After dinner, I had very bad pain, redness, and swelling at the injection site. It was also very hot to the touch. It was so bad, I could barely lift my harm, if my husband just lightly put his finger on the site, it was very painful. (I have very high pain threshold. I did not use any pain medication with both my natural childbirths.) That night I was not feeling well. Kind of nauseous, fevery, a heavy-feeling everywhere. My arm hurt and I took 2 Aleve tablets. I went up to bed around 10 pm and fell asleep with a mild headache. As the hours passed the mild headache turned into a bad headache and throughout the night I had very fitful sleep. Around 6AM on Tuesday, I asked that my husband bring me 2 Excedrin Migraine tablets. I then slept until around 6PM. When I got up, my whole body ached. I went back to be after eating dinner. I took Aleve again. I slept until Wednesday morning though intermittently awoke because of the arm pain. On Wednesday morning, I felt a lot better but was exhausted. Slept on and off the entire day. On Thursday (today) I woke up feeling pretty normal (except for the sore arm at the injection site) and expected to be able to get on with the day. But again, I was very exhausted and was not very productive. Tonight, the injection site still hurts and is warm to the touch. Please feel free to call if you have any additional questions.
One hr & fifteen min p/vax developed total body rash, difficulty in swallowing, SOB, & itching; Seen in ER tx epinephrine & DPH;
PATIENT PASSED OUT/VOMIT/ANXIOUS. EMT VISIT/ BP 140/80, RECOVERED INAPPROXIMATELY 10MINUTES
BODY ACHES; VOMITING; CHILLS; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced body aches. On 07-APR-2021, the subject experienced vomiting. On 07-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, body aches, and vomiting. This report was non-serious.
Chest pressure and hard to take a deep breath a minute after the shot. It resolved while sitting down for 10 minutes. Headache and teeth pain later in the day that lasted for 3 days. Left arm pain down to my fingers from the night of the shot until 5 days later.
Mom describes staring episodes for about 2-3 hours after 2 m vaccines. She would have spells that would last about 10 min each where mom could not get her out of a staring episode pt did not have any episodes after the day of vaccines. Mom did not report until 4 month exam on 8/14/2017.
On 09/13/2022 I received my Covid-19 vaccine. On 02/01/2023 I found a breast lump and needed to have a mammogram. It was found that I developed 2 lumps I did not have before. Swollen lymph nodes and two breast lumps.
Following the vaccination, patient stated that she felt dizzy and her arm was warm and tingling at the site of injection. Blood pressure was normal. Patient normalized after 30 minutes of being.
This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 56-year-old female patient who received SHINGRIX for prophylaxis. On 24th July 2018 12:00, the patient received the 1st dose of SHINGRIX. On 24th July 2018, several hours after receiving SHINGRIX, the patient experienced muscle pain, influenza-like symptoms and injection site warmth. On 25th July 2018, the patient experienced sweating, weakness, chills, fever and leg pain. On an unknown date, the outcome of the muscle pain, influenza-like symptoms and injection site warmth were recovering/resolving and the outcome of the sweating, weakness, chills, fever and leg pain were unknown. It was unknown if the reporter considered the muscle pain, influenza-like symptoms, sweating, weakness, chills, fever, injection site warmth and leg pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX around noon. Later that evening after vaccination, the patient experienced warmth and arm pain. She noted it was muscle pain. One day after vaccination, the patient experienced leg pain, weakness, fever, chills and sweating. On 25th July 2018, in the morning the patient experienced hurting in her legs and very weak. In the night of 25th July 2018, the patient experienced chills and a fever of 100 degree F. She slept well but awoke with sweats. The patient had plan to get the 2nd shot at this point, but was concerned if the symptoms would be worse. The patient was referred to her physician and the prescribing information was reviewed. The patient noted symptoms were not as bad as initially. The patient declined the healthcare professional (HCP) contact, as the HCP was not aware of her getting the vaccine.
I am allergic to eggs and 10 to 15 minutes after administration I became wheezing and shortness of breath, severe headache, and became hoarse.
Patient stated about 2 months after receiving vaccine, he noticed he was losing weight. Patient stated he lost about 22 pounds since he's had the vaccine. At the time of vaccination, he weighed 252, and now he weighs 230. Patient also stated he's been having body aches.
bruised at injection site and redness and soreness  3-4 inches below the  injection site applied neosporin and cortisone cream
Ache from head to toe, joints, head , skin.  Very weak could hardly get to bathroom.  severe chills, teeth chattering and shivering.  Believe had temp, but did not confirm.  Severe symptoms begin about 12 hr from injection, lasted approx12 hrs from onset, with moderate symptoms 6 additional hrs.  Symptoms subsided after 48 hrs, but still weak.  Did not seek medical treatment, did take some Tylenol but not much effect.  wife had exact same reactions. We did travel via car from elevation 700' to 5, 000' that afternoon after the morning injection. Blood type A+
Patient developed fever of 104.3F in the PM of 01/13/2007. She had rash similar to measles rash on her legs, stomach, and ears which began on 01/12/2007. She was treated with infant's dosage of acetaminophen and Motrin. Fever lowered to 101 by 01/15/2007 and to normal body temperature by 01/16/2007. No other symptoms were present.
A spontaneous report has been received from a health professional via Med rep. concerning a 46 weeks 1 day old female patient. Patient concomitant medications and relevant history was not reported. It was reported that the patient was 11 months old and had administered nasal FLUMIST Vaccine on 10-Nov-2015. Patient since administration has not experienced any symptoms. It was patient's first flu vaccination. At the time of administration, patient was not taking any other medications. The outcome of the event of inadvertent administration was unknown. The reporter assessed the event of inadvertent administration to be non-serious. The reporter and company physician considered that there was no causal relationship between the event inadvertent administration and FLUMIST.
Weakness of left arm. Unable to raise arm above the horizontal. Diminished range of motion of the left arm.
Joint pain Metallic taste Fever (as high as 102) Chills Headache Body ache Fatigue
Pt was given a dose from a vial that was >12 hour post puncture. Vial was left at room temp at 6pm and pt was given dose at around 10:20am. Pt was informed of error and pt reported feeling "bad" after receiving shot. She states cold like symptoms, fever, chills, headache started the same evening (Friday) that she received the shot and was gone by Sunday evening, except for the headache. Headache has not gone away and has been ongoing 24/7. Pt has an upcoming appointment with her physician in about a week.
Patient had syncopal episode falling from seated position in chair 10 minutes after vaccination. Pt had low BP and was transported to the hospital
Reported Temp 100.6F, difficulty sleeping, dizzy, lightheaded, flushed , nausea with diarrhea for 12 hours. All symptoms resolved. Patient Included the following information: 1 st dose Phizer EH 9899 2nd Dose Phizer EK 9231
pt vax in 12/98 & in 4/99 pt was dx of type 1 diabetes
COVID 19 Treatment, brand=Paxlovid; COVID 19 Treatment, brand=Paxlovid; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 78-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2022 as dose 5 (booster), single (Lot number: GH9694) at the age of 78 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "bronchiectasis" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "PSVT history" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing). Concomitant medication(s) included: BUDESONIDE nasal. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment, brand=Paxlovid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective. It was unknown if therapeutic measures were taken as a result of covid-19.  Clinical course: Felt fine but started paxlovid after positive covid test due to her having bronchiectasis.; Sender's Comments: Based on the available information and close temporal association, a possible causal relationship cannot be excluded between the suspect vaccine BNT162b2 and the reported events "drug ineffective", "COVID-19".
Pharmacist reports that 15 year old patient reports that he may have received one dose of VARIVAX at the age of 3.; This spontaneous report was received from a pharmacist referring to a 15 year old male patient. The patient's concurrent conditions, medical history and concomitant medications were not provided.  On an unknown date (reported as at the age of 3), the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (dose, frequency, route, lot/batch # and expiration date were not provided) for prophylaxis. The reported stated that there was a possible adverse event due to possible interruption of dosing schedule. No additional adverse events reported.
minor headache; minor fatigue; arm soreness lasted 3-4 days.; Has not got menstrual cycle since first dose was administered; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (minor headache), FATIGUE (minor fatigue), PAIN IN EXTREMITY (arm soreness lasted 3-4 days.) and MENSTRUAL DISORDER (Has not got menstrual cycle since first dose was administered) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (minor headache), FATIGUE (minor fatigue), PAIN IN EXTREMITY (arm soreness lasted 3-4 days.) and MENSTRUAL DISORDER (Has not got menstrual cycle since first dose was administered). On 06-Mar-2021, HEADACHE (minor headache) and FATIGUE (minor fatigue) had resolved. On 08-Mar-2021, PAIN IN EXTREMITY (arm soreness lasted 3-4 days.) had resolved. At the time of the report, MENSTRUAL DISORDER (Has not got menstrual cycle since first dose was administered) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   This case was linked to MOD-2021-089544 (Patient Link).
Varivax received at previous doctor's office on 01/24/1998 presented in office 06/17/2005 with rash since the beginning of the week.  Diagnosed with chickenpox post vaccine.
Intense pain at vaccination site, can't use my arm for anything, fever 38.9C that only goes down with ibuprofen. Chills, pain all over the body, can't put my feet on the floor because of plantar pain on my feet. Rib pain and axillary pain on my left side, lack of appetite, throat pain, stomach pain
Bruise at the injection site and a large red rash that covered most of her arm, the spot was raised and hot to touch.
ERYTHEMATOUS-BASED VESICLES AND PUSTULES OVER THE BACK AND BUTTOCK AREA - 13 DAYS POST VARICELLA VACCINE  dx: VACCINE INDUCED VARICELLA
Client fully vaccinated for COVID-19 - received dose #1 of Moderna on 2/2/2021 and dose #2 of Moderna on 3/2/2021 tested positive via NAAT on 6/18/2021. Client was hospitalized for COVID-19 and died on 7/6/2021
The pt's mom described objectively "left leg was swollen from his kneecap to the edge of his diaper". Mom states that she put a cool cloth on the swelling site and the swelling was reduced in approx. an hour. Follow-up with the pt on the next day, Mom reported "is ok" and "swelling is gone".
fever, chills, cold sweats, pharyngitis, ear infections, swollen tonsils and adenoids, pain at injection site.
Approx 3 hrs after injections, patient began experiencing rapid HR and SOB-call 911 if symptoms worsen.